Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$540M |
| 2 |
Citizens Financial Group
CFG
|
+$304M |
| 3 |
Analog Devices
ADI
|
+$303M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$293M |
| 5 |
Travelers Companies
TRV
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$548M |
| 2 |
Micron Technology
MU
|
+$461M |
| 3 |
Citigroup
C
|
+$334M |
| 4 |
Broadcom
AVGO
|
+$319M |
| 5 |
AbbVie
ABBV
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.99% |
| 2 | Financials | 5.48% |
| 3 | Industrials | 4.89% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Healthcare | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGP
3951
PUT
DELISTED
Teekay LNG Partners L.P.
TGP
| $1.16M | ﹤0.01% |
65,300
+27,100
| +71% | +$470K |
|
3952
Blackstone
BX
$118B
| $1.16M | ﹤0.01% |
+34,785
| New | +$1.14M |
|
|
SPPI
3953
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.16M | ﹤0.01% |
82,514
-32,400
| -28% | -$293K |
|
3954
PUT
Global Payments
GPN
$22.7B
| $1.16M | ﹤0.01% |
12,200
-7,800
| -39% | -$735K |
|
3955
First Financial Bancorp
FFBC
$3.57B
| $1.16M | ﹤0.01% |
44,273
+33,001
| +293% | +$844K |
|
3956
Invesco CurrencyShares Swiss Franc Trust
FXF
$397M
| $1.16M | ﹤0.01% |
11,854
+812
| +7% | +$79.9K |
|
3957
PUT
Pool Corp
POOL
$7.32B
| $1.16M | ﹤0.01% |
10,700
+5,500
| +106% | +$595K |
|
3958
PUT
JB Hunt Transport Services
JBHT
$24.9B
| $1.16M | ﹤0.01% |
10,400
-20,700
| -67% | -$2M |
|
|
MPT
3959
Medical Properties Trust
MPT
$2.4B
| $1.16M | ﹤0.01% |
87,976
-916,942
| -91% | -$11.8M |
|
3960
Greenlight Captial
GLRE
$503M
| $1.15M | ﹤0.01% |
53,239
+15,940
| +43% | +$344K |
|
3961
CALL
Grand Canyon Education
LOPE
$3.76B
| $1.15M | ﹤0.01% |
12,700
+1,700
| +15% | +$136K |
|
3962
Petrobras Class A
PBR.A
$103B
| $1.15M | ﹤0.01% |
119,368
+101,781
| +579% | +$887K |
|
3963
State Street SPDR S&P Pharmaceuticals ETF
XPH
$509M
| $1.15M | ﹤0.01% |
+27,097
| New | +$1.15M |
|
3964
CALL
Visteon
VC
$2.83B
| $1.15M | ﹤0.01% |
9,300
+5,000
| +116% | +$567K |
|
3965
CALL
Banc of California
BANC
$3.09B
| $1.15M | ﹤0.01% |
55,400
-27,600
| -33% | -$544K |
|
|
DVAX
3966
PUT
DELISTED
Dynavax Technologies
DVAX
| $1.15M | ﹤0.01% |
53,500
-24,200
| -31% | -$383K |
|
3967
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$295M
| $1.15M | ﹤0.01% |
33,309
-175
| -0.5% | -$5.92K |
|
|
OIL
3968
CALL
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
| $1.15M | ﹤0.01% |
213,700
+122,800
| +135% | +$618K |
|
3969
TransUnion
TRU
$15.4B
| $1.15M | ﹤0.01% |
24,311
-1,105,059
| -98% | -$50.5M |
|
3970
CALL
Halozyme
HALO
$11.6B
| $1.15M | ﹤0.01% |
66,100
+14,900
| +29% | +$202K |
|
|
ORBC
3971
DELISTED
ORBCOMM, Inc.
ORBC
| $1.15M | ﹤0.01% |
109,570
+73,220
| +201% | +$810K |
|
3972
CALL
ICICI Bank
IBN
$107B
| $1.15M | ﹤0.01% |
133,710
-89,320
| -40% | -$816K |
|
3973
TE Connectivity
TEL
$63.3B
| $1.15M | ﹤0.01% |
13,785
-72,756
| -84% | -$5.85M |
|
3974
CALL
TG Therapeutics
TGTX
$7.64B
| $1.15M | ﹤0.01% |
96,600
-21,300
| -18% | -$243K |
|
3975
Cambria Global Value ETF
GVAL
$594M
| $1.14M | ﹤0.01% |
45,334
-81,587
| -64% | -$2.03M |
|
Similar funds
Citadel Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, Citadel Advisors held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Citadel Advisors's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.1% a quarter earlier, followed by Financials and Industrials.
- Citadel Advisors's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
- Citadel Advisors added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
- Citadel Advisors's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
- Citadel Advisors fully exited Citigroup in Q3 2017, selling an estimated $334M.
- Citadel Advisors's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
- Citadel Advisors opened 1,223 new positions and closed 1,164 in Q3 2017.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.